Enhancement of diphenylhydantoin induced anticonvulsant activity by a shaking stress

F. R. Domer, J. C. Allen, Darrell Davidson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Groups of 10 mice were given doses of saline or 6, 8 or 10 mg/kg of diphenylhydantoin i.p. At either 10, 20 or 30 min later they were exposed to a supramaximal electroshock. Some mice were also placed on a shaker and shaken at either 3.1 or 4.6 Hz following drug administration. This shaking caused a more rapid onset and more intense anticonvulsant effect. The enhancement was much greater in the animals exposed to the higher intensity stress. Premedication with either phenoxybenzamine and/or propranolol 30 min before administration of the diphenylhydantoin diminished or even reversed the enhancement of the anticonvulsant activity caused by the higher intensity stress. It was concluded that the stress induced enhancement of diphenylhydantoin's anticonvulsant activity involved activation of the sympathetic nervous system, likely release of epinephrine from the adrenal medulla. The combination of phenoxybenzamine, higher intensity shaking and electroshock was lethal to many of the animals.

Original languageEnglish (US)
Pages (from-to)363-370
Number of pages8
JournalArchives Internationales de Pharmacodynamie et de Therapie
Volume211
Issue number2
StatePublished - 1974
Externally publishedYes

Fingerprint

Phenytoin
Anticonvulsants
Phenoxybenzamine
Electroshock
Adrenal Medulla
Premedication
Sympathetic Nervous System
Propranolol
Epinephrine
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology

Cite this

Enhancement of diphenylhydantoin induced anticonvulsant activity by a shaking stress. / Domer, F. R.; Allen, J. C.; Davidson, Darrell.

In: Archives Internationales de Pharmacodynamie et de Therapie, Vol. 211, No. 2, 1974, p. 363-370.

Research output: Contribution to journalArticle

Domer, F. R. ; Allen, J. C. ; Davidson, Darrell. / Enhancement of diphenylhydantoin induced anticonvulsant activity by a shaking stress. In: Archives Internationales de Pharmacodynamie et de Therapie. 1974 ; Vol. 211, No. 2. pp. 363-370.
@article{b9898acd108e41208ef305294e84dfed,
title = "Enhancement of diphenylhydantoin induced anticonvulsant activity by a shaking stress",
abstract = "Groups of 10 mice were given doses of saline or 6, 8 or 10 mg/kg of diphenylhydantoin i.p. At either 10, 20 or 30 min later they were exposed to a supramaximal electroshock. Some mice were also placed on a shaker and shaken at either 3.1 or 4.6 Hz following drug administration. This shaking caused a more rapid onset and more intense anticonvulsant effect. The enhancement was much greater in the animals exposed to the higher intensity stress. Premedication with either phenoxybenzamine and/or propranolol 30 min before administration of the diphenylhydantoin diminished or even reversed the enhancement of the anticonvulsant activity caused by the higher intensity stress. It was concluded that the stress induced enhancement of diphenylhydantoin's anticonvulsant activity involved activation of the sympathetic nervous system, likely release of epinephrine from the adrenal medulla. The combination of phenoxybenzamine, higher intensity shaking and electroshock was lethal to many of the animals.",
author = "Domer, {F. R.} and Allen, {J. C.} and Darrell Davidson",
year = "1974",
language = "English (US)",
volume = "211",
pages = "363--370",
journal = "Archives Internationales de Pharmacodynamie et de Therapie",
issn = "0003-9780",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Enhancement of diphenylhydantoin induced anticonvulsant activity by a shaking stress

AU - Domer, F. R.

AU - Allen, J. C.

AU - Davidson, Darrell

PY - 1974

Y1 - 1974

N2 - Groups of 10 mice were given doses of saline or 6, 8 or 10 mg/kg of diphenylhydantoin i.p. At either 10, 20 or 30 min later they were exposed to a supramaximal electroshock. Some mice were also placed on a shaker and shaken at either 3.1 or 4.6 Hz following drug administration. This shaking caused a more rapid onset and more intense anticonvulsant effect. The enhancement was much greater in the animals exposed to the higher intensity stress. Premedication with either phenoxybenzamine and/or propranolol 30 min before administration of the diphenylhydantoin diminished or even reversed the enhancement of the anticonvulsant activity caused by the higher intensity stress. It was concluded that the stress induced enhancement of diphenylhydantoin's anticonvulsant activity involved activation of the sympathetic nervous system, likely release of epinephrine from the adrenal medulla. The combination of phenoxybenzamine, higher intensity shaking and electroshock was lethal to many of the animals.

AB - Groups of 10 mice were given doses of saline or 6, 8 or 10 mg/kg of diphenylhydantoin i.p. At either 10, 20 or 30 min later they were exposed to a supramaximal electroshock. Some mice were also placed on a shaker and shaken at either 3.1 or 4.6 Hz following drug administration. This shaking caused a more rapid onset and more intense anticonvulsant effect. The enhancement was much greater in the animals exposed to the higher intensity stress. Premedication with either phenoxybenzamine and/or propranolol 30 min before administration of the diphenylhydantoin diminished or even reversed the enhancement of the anticonvulsant activity caused by the higher intensity stress. It was concluded that the stress induced enhancement of diphenylhydantoin's anticonvulsant activity involved activation of the sympathetic nervous system, likely release of epinephrine from the adrenal medulla. The combination of phenoxybenzamine, higher intensity shaking and electroshock was lethal to many of the animals.

UR - http://www.scopus.com/inward/record.url?scp=0016295386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016295386&partnerID=8YFLogxK

M3 - Article

C2 - 4460921

AN - SCOPUS:0016295386

VL - 211

SP - 363

EP - 370

JO - Archives Internationales de Pharmacodynamie et de Therapie

JF - Archives Internationales de Pharmacodynamie et de Therapie

SN - 0003-9780

IS - 2

ER -